tirzepatide diabetes prevention Cipla launches Yurpeak® (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 mellitus (T2DM) — two of the country's most pressing health challenges. Cipla has the rights to distribute Tirzepatide Shows Powerful Diabetes-Prevention Effect
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


























